ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Barman76
|
510 |
148K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
510
|
148K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Share Cafe Webinar - Potency assay data was in place for GvHD trial
|
|
Barman76
|
15 |
4.3K |
3 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
15
|
4.3K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
|
|
Barman76
|
166 |
77K |
8 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
166
|
77K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Barman76
|
102 |
37K |
14 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
102
|
37K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
Barman76
|
512 |
122K |
2 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
512
|
122K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Taken up the entitlement?
|
|
Barman76
|
544 |
129K |
1 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
544
|
129K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
15 Days to All Doubt is Removed!
|
|
Barman76
|
8 |
2.7K |
2 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
8
|
2.7K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Barman76
|
716 |
197K |
0 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
716
|
197K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
Barman76
|
71 |
17K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
17K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
Barman76
|
71 |
17K |
4 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
17K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Barman76
|
184 |
46K |
5 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
184
|
46K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Barman76
|
574 |
189K |
6 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
574
|
189K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Barman76
|
574 |
189K |
3 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
189K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Barman76
|
904 |
273K |
14 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
904
|
273K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Barman76
|
88 |
28K |
2 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
88
|
28K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Barman76
|
88 |
28K |
3 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
88
|
28K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Barman76
|
904 |
273K |
4 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
904
|
273K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
How will you celebrate when FDA gives the Tick
|
|
Barman76
|
82 |
37K |
6 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
82
|
37K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
How will you celebrate when FDA gives the Tick
|
|
Barman76
|
82 |
37K |
5 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
82
|
37K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Barman76
|
1.3K |
540K |
1 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Barman76
|
1.3K |
540K |
4 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Barman76
|
1.3K |
540K |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Barman76
|
1.3K |
540K |
9 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Barman76
|
3.4K |
1.1M |
8 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Barman76
|
3.4K |
1.1M |
10 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Barman76
|
17K |
6.5M |
8 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
17K
|
6.5M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Barman76
|
4.9K |
2.3M |
4 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
4.9K
|
2.3M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Barman76
|
9.3K |
2.6M |
2 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
9.3K
|
2.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Barman76
|
4.9K |
2.3M |
4 |
10/06/23 |
10/06/23 |
ASX - By Stock
|
4.9K
|
2.3M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
Barman76
|
55 |
21K |
5 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
55
|
21K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT
|
|
Barman76
|
56 |
15K |
2 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
56
|
15K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT
|
|
Barman76
|
56 |
15K |
3 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
56
|
15K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Barman76
|
4 |
1.3K |
4 |
20/05/23 |
20/05/23 |
ASX - By Stock
|
4
|
1.3K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Barman76
|
17K |
6.5M |
6 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
17K
|
6.5M
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Capital Raising Presentation
|
|
Barman76
|
225 |
52K |
1 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
225
|
52K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
CYP For Sale @ $10 to $20
|
|
Barman76
|
149 |
49K |
1 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
149
|
49K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
CYP For Sale @ $10 to $20
|
|
Barman76
|
149 |
49K |
1 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
149
|
49K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
Barman76
|
2.1K |
667K |
2 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
2.1K
|
667K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Barman76
|
17K |
6.5M |
2 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
17K
|
6.5M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Barman76
|
17K |
6.5M |
2 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
17K
|
6.5M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
What could be the hold up?
|
|
Barman76
|
28 |
8.6K |
2 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
28
|
8.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
Barman76
|
355 |
95K |
6 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
355
|
95K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
Barman76
|
355 |
95K |
9 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
355
|
95K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: AGM Presentations
|
|
Barman76
|
54 |
10K |
1 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
54
|
10K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
Barman76
|
355 |
95K |
6 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
355
|
95K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
What questions do holders want asked at the AGM?
|
|
Barman76
|
120 |
27K |
1 |
20/11/22 |
20/11/22 |
ASX - By Stock
|
120
|
27K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Fujifilm Exercises License Option in GvHD
|
|
Barman76
|
327 |
124K |
0 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
327
|
124K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Fujifilm Exercises License Option in GvHD
|
|
Barman76
|
327 |
124K |
0 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
327
|
124K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
Barman76
|
394 |
82K |
1 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
394
|
82K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Letter to Shareholders, Notice of AGM & Proxy Form
|
|
Barman76
|
52 |
8.2K |
1 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
52
|
8.2K
|
1
|
|